Author
Listed:
- Sergey Rodin
(Karolinska Institute)
- Liselotte Antonsson
(Intervention and Technology, Karolinska Institute and Karolinska University Hospital, Huddinge)
- Colin Niaudet
(Vascular Biology, Karolinska Institute)
- Oscar E. Simonson
(Advanced Center for Translational Regenerative Medicine (ACTREM), Karolinska Institute and Karolinska University Hospital)
- Elina Salmela
(Research Programs Unit, Molecular Neurology, University of Helsinki
Folkhälsan Institute of Genetics)
- Emil M. Hansson
(Cardiovascular Research Center, Massachusetts General Hospital, Charles River Plaza/CPZN 3200, 185 Cambridge Street)
- Anna Domogatskaya
(Karolinska Institute)
- Zhijie Xiao
(Karolinska Institute)
- Pauliina Damdimopoulou
(Intervention and Technology, Karolinska Institute and Karolinska University Hospital, Huddinge)
- Mona Sheikhi
(Intervention and Technology, Karolinska Institute and Karolinska University Hospital, Huddinge)
- José Inzunza
(Intervention and Technology, Karolinska Institute and Karolinska University Hospital, Huddinge)
- Ann-Sofie Nilsson
(Karolinska Institute)
- Duncan Baker
(Sheffield Diagnostic Genetic Services, Sheffield Children’s NHS Trust)
- Raoul Kuiper
(FENO, Karolinska Institute, Huddinge, Karolinska Hospital)
- Yi Sun
(BioLamina AB, Löfströms Allé 5A)
- Elisabeth Blennow
(Karolinska University Hospital)
- Magnus Nordenskjöld
(Karolinska University Hospital)
- Karl-Henrik Grinnemo
(Advanced Center for Translational Regenerative Medicine (ACTREM), Karolinska Institute and Karolinska University Hospital)
- Juha Kere
(Research Programs Unit, Molecular Neurology, University of Helsinki
Folkhälsan Institute of Genetics
Karolinska Institute)
- Christer Betsholtz
(Vascular Biology, Karolinska Institute)
- Outi Hovatta
(Intervention and Technology, Karolinska Institute and Karolinska University Hospital, Huddinge)
- Karl Tryggvason
(Karolinska Institute
Cardiovascular and Metabolic Disorders Program, Duke-NUS)
Abstract
Lack of robust methods for establishment and expansion of pluripotent human embryonic stem (hES) cells still hampers development of cell therapy. Laminins (LN) are a family of highly cell-type specific basement membrane proteins important for cell adhesion, differentiation, migration and phenotype stability. Here we produce and isolate a human recombinant LN-521 isoform and develop a cell culture matrix containing LN-521 and E-cadherin, which both localize to stem cell niches in vivo. This matrix allows clonal derivation, clonal survival and long-term self-renewal of hES cells under completely chemically defined and xeno-free conditions without ROCK inhibitors. Neither LN-521 nor E-cadherin alone enable clonal survival of hES cells. The LN-521/E-cadherin matrix allows hES cell line derivation from blastocyst inner cell mass and single blastomere cells without a need to destroy the embryo. This method can facilitate the generation of hES cell lines for development of different cell types for regenerative medicine purposes.
Suggested Citation
Sergey Rodin & Liselotte Antonsson & Colin Niaudet & Oscar E. Simonson & Elina Salmela & Emil M. Hansson & Anna Domogatskaya & Zhijie Xiao & Pauliina Damdimopoulou & Mona Sheikhi & José Inzunza & Ann-, 2014.
"Clonal culturing of human embryonic stem cells on laminin-521/E-cadherin matrix in defined and xeno-free environment,"
Nature Communications, Nature, vol. 5(1), pages 1-13, May.
Handle:
RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4195
DOI: 10.1038/ncomms4195
Download full text from publisher
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:5:y:2014:i:1:d:10.1038_ncomms4195. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.